Skip to content

LIGAND PHARMACEUTICALS INCORPORATED

LGND LGNDZ LGNXZ LGNYZ LGNZZ

CIK 0000886163

← back to feed
Revenue (TTM)
$260.14M
+60.4% YoY Q1 May 2026
Net Income (TTM)
$66.32M
+3,186.6% YoY Q1 May 2026
EPS Diluted (TTM)
$3.04
+2,886.4% YoY Q1 May 2026
Gross Margin
95.8%
Q1 May 2026
Operating Margin
17.1%
Q1 May 2026
Net Margin
25.5%
Q1 May 2026
Free Cash Flow (TTM)
$72.97M
Q1 May 2026
Cash
$115.08M
Q1 May 2026
Total Debt
$27.5M
Q1 May 2026
Shares Outstanding
20.04M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings